50-years journey of heart transplant
- PMID: 37981922
- PMCID: PMC10654392
- DOI: 10.1016/j.mjafi.2023.03.008
50-years journey of heart transplant
Abstract
Heart transplant is an established modality for the treatment of heart disease refractory to medical therapy. The last 50 years have seen the evolution of immune suppression therapy and standardization of protocols which have significantly improved outcomes following cardiac transplants. Donor availability is the main limiting factor and has restricted the number of heart transplants worldwide. Simultaneously, left ventricular assist devices have evolved to provide a "bridge" for recovery and transplant and alternatively as destination therapy to those waiting for the availability of a donor. This review article provides an overview of the current status of heart transplants after half a century and specific issues pertaining to our country.
Keywords: Heart failure; Heart transplant; Left ventricular assist device.
© 2023 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.
Conflict of interest statement
The authors have none to declare.
References
-
- Ponikowski P., Anker S.D., Al Habib K.F., et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4. 2. - PubMed
-
- Cook C., Cole G., Asaria P., Jabbour R., Francis D.P. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–376. - PubMed
-
- Costanzo M.R., Mills R.M., Wynne J. Characteristics of “stage D” heart failure: insights from the acute decompensated heart failure national registry longitudinal module (ADHERE LM) Am Heart J. 2008;155(2):339–347. - PubMed
-
- Chaturvedi V., Parakh N., Seth S., et al. Heart failure in India: the INDUS (India Ukieri study) study. J Pract Cardiovasc Sci. 2016;2:28–35.
Publication types
LinkOut - more resources
Full Text Sources
